Background/Aims: Tuberculosis induces bone loss and activates Th1 cells that play an important role in the host defense of Bacille Calmette-Guérin tuberculosis vaccine. However, the role of tuberculosis-activated Th1 cells in differentiation of osteoclast precursors to osteoclasts is unclear. As secretion of IFN-γ in Th1 cells is induced by tuberculosis, we aimed to investigate the role of anti-IFN-γ antibody on the differentiation and activation of osteoclasts in bone marrow monocyte-derived macrophages (BMMs). Methods: BMMs were isolated and co-cultured with CD4+T helper 1 cells (Th1 cells), pretreated with anti-IFN-γ antibody. Then, cell proliferation, expression and release of cytokines, formation of actin ring, differentiation of osteoclasts and bone resorption function were measured by CCK8 assay, qRT-PCR/Western blot/flow cytometry, ELISA, immunofluorescence, tartrate-resistant acidic phosphatase (TRAP) staining and bone absorbance assay, respectively. Results: Anti-IFN-γ antibody inhibited the cell viability of BMMs, and induced the expressions of RANKL, TNF-α, NF-κB and TRAF6 in BMMs. In addition, it led to increased expression levels of RANK on cell surfaces, and increased production of RANKL, TNF-α, MCP-1 and SDF-1. Anti-IFN-γ antibody also induced the expression of osteoclast differentiation factor and actin ring formation, but inhibited the expression of osteoprotegerin. TRAP staining and bone resorption assays showed that anti-IFN-γ antibody induced an increase in osteoclast formation and bone resorption.
Introduction
Tuberculosis continues to be a public health problem worldwide. Extra-pulmonary tuberculosis accounts for one-third of all types of tuberculosis. Osteoarthritis tuberculosis is one of the main manifestations of extra-pulmonary tuberculosis, and accounts for 35 ~ 50% of extra-pulmonary tuberculosis. Osteoarthritis tuberculosis is a chronic and progressive disease caused by Mycobacterium tuberculosis and is characterized by bone loss due to an imbalance in bone remodeling and bone resorption [1] [2] [3] .
Bone formation and bone resorption are coupled processes and together function to maintain dynamic bone equilibrium [4, 5] . Osteoblasts and osteoclasts are basic functional cells that participate in bone remodeling. Indeed, osteoclasts are the only highly specific multinucleated giant cells with bone resorption function in vivo [6] . Osteoclasts differentiate from osteoclast precursor cells in the bone marrow monocyte-phagocytic system, such as bone marrow monocyte-derived macrophages (BMMs) [7] . After infection around the bone, bacterial endotoxins and various inflammatory factors induce activation and proliferation of osteoclasts, inhibit the activity of osteoblasts, cause disequilibrium in bone metabolism, and finally induce pathological bone resorption [1] [2] [3] . Several studies have confirmed that the differentiation process of osteoclasts involves the regulation of NF-kappa B activation receptor (RANK) / osteoprotegerin (OPG)/RANK ligand (RANKL) axis system [8] . The axis is activated by microbiological antigens, denatured collagen and various chemokines and inflammatory factors, and is the main regulatory mechanism mediating osteoclast differentiation and maturation [9] [10] [11] . Moreover, inhibition of osteoclastogenesis is also inhibited by the RANKL/ROS/JAK2 pathway [12, 13] .
The cellular immune response mediated by CD4+T helper cells (Th cells) greatly impacts resorption of bone in the host [14, 15] . The activated Th cells secrete cytokines that exert different effects through different signaling pathways, and play an important role in the regulation of bone immunity [16] . Studies suggest that differentiation of Th1 from the initial CD4+T cell population predominates in the early/stable stage of bone disease [17] . Th1 cells mediate the cellular immune response, mainly through the secretion of interferon-γ (INF-γ). Most studies suggest that INF-γ produced by activated Th1 strongly inhibits the differentiation of osteoclast precursor cells into osteoclasts in vitro [18, 19] . IFN-γ strongly inhibits RANKL-induced activation of the transcription factors NF-κB and JNK by inducing rapid degradation of the adapter protein TRAF6 in the RANKL-RANK signaling pathway, blocking the entire RANKL-RANK signaling pathway and eventually inhibiting osteoclast formation [20] . The role of IFN-γ in the differentiation of osteoclast precursors depends on the complex regulation of the environment in which the cells are located and the inflammatory signaling pathways.
Tuberculosis induces bone loss by activating RANKL signaling [21] . Tuberculosisactivated Th1 cells play an important role in immune response in tuberculosis [22] . However, the role of tuberculosis-activated Th1 cells in differentiating osteoclast precursors to osteoclasts is unclear. Th1 cells in tuberculosis patients produce increasing levels of IFN-γ [22, 23] . In the present study, we co-cultured BMMs with isolated Th1 cells, and investigated the effects of anti-IFN-γ antibody on bone resorption and differentiation. After centrifugation for 10 min at 1, 800 r/min and removal of supernatant, the antigen presenting cells were prepared. The CD4+T cells were isolated by magnetic beads (Mihenyi's, Germany). Flow cytometry showed that CD4+T cells of >99% were positive for TCR-Tg by staining with anti TCR-Tg specific antibody (BD Bioscience). For tuberculosis, TCR-Tg CD4+T cells and antigen presenting cells (1:6) were cultured for 3-4 days in the presence of Bacille Calmette-Guérin (BCG, China Biotechnology co. LTD) and IL-12 (2 ng/ml, PeproTech, USA). Then, cells were incubated with IL-2 (10 µg/m1, PeproTech). Cells were passaged over 3 days at a time. The third passage Th1 cells were mixed with antigen presenting cells (1:6), treated with BCG (1 µg/ m1) for 5 h, and then pre-incubated with anti-IFN-γ antibody for 24 h and used in subsequent experiments.
Materials and Methods

Isolation of mouse bone marrow monocyte/macrophage cell line (BMMs)
Mouse femoral and tibial canal lavage fluids were placed in a 50 ml centrifuge tube containing 3, 000 u heparin, diluted with 20 ml PBS, and slowly added to 20 ml Ficoll (1.077g/ml, Solarbio, China). After centrifugation at 1, 500 rpm, for 20 min at 20°C monocytes were collected and re-suspended in RPMI-1640 containing 10% new calf serum.
Co-culture of BMMs and Th1 cells
Transwells with 0.4 μm diameter polycarbonate membranes were selected to conduct non-contact coculture of BMMs and Th1 cells with 24-well plates. BMMs were seeded in the upper chamber (5×10 5 cells) and Th1 (6×10 3 cells) cells were seeded in the lower chamber. Th1 cells were pre-incubated with anti-IFN-γ antibody for 24 h, and the adherent BMMs were treated with recombinant human M-CSF (rhM-CSF, 25 ng/ mL, PeproTech) and human recombinant RANKL (rhRANKL, 30 ng/mL, PeproTech). Osteoclast formation was evaluated after 6 days of culture.
Enzyme Linked Immunosorbent Assay (ELISA)
The adherent BMMs were cultured with Th1 cells, with or without pre-incubated anti-IFN-γ antibody for 24 h, in the presence of rhM-CSF and rhRANKL for 6 days. Then, levels of IFN-γ, TNF-α, MCP-1, RANKL and SDF-1 were examined using an ELISA kit (Elabscience, USA), according to the manufacturer's instructions. After incubation with biotinylated antibody (100 μL/ well) for 1 h at 37℃, the plates were washed 5 times in PBS, incubated with enzyme substrate for 30 min at 37°C and then with chromogenic substrate 3, 3',5, 5'-Tetramethylbenzidine (TMB) solution for 15 min at 37°Cin the dark. The reaction was terminated by 100 μL stop solution. The optical density was read by a microplate reader at 450 nm.
qRT-PCR
After treatment, total RNA from BMMs was isolated using Trizol reagent (Invitrogen), according to the standard protocol. qRT-PCR was performed using the SYBR Premix Ex TaqTM (Takara, Shiga, Japan) using Real-Time PCR System (Applied Biosystems, USA), according to the manufacturer's instructions. The primers used in this study are listed in Table 1 . The tests were performed in triplicate. Gene expression was normalized to GAPDH expression, and calculated using the method of 2 -ΔΔCt . 
Western blot
Proteins were extracted from BMMs using the RIPA lysis buffer and quantified by Pierce BCA Protein Assay Kit (Thermo, USA). Proteins were separated by 10% SDS-PAGE and then transferred onto a nitrocellulose membrane. After blocking with 5% skim milk, and incubating with primary antibodies that included anti-GAPDH, IFN-γ, RANKL, TNF-α, NF-κB (p65), TRAF6 and osteoprotegerin (OPG) (Abcam, USA) overnight at 4°C, the membranes were treated with HRP-conjugated secondary antibody (Bioworld, China) for 1 h at room temperature. The blots were visualized using the ECL-Plus reagent (Millipore, Billerica, MA, USA).
Flow cytometry detection of RANK on the cell surface
The adherent BMMs were cultured with Th1 cells, with or without pre-incubated anti-IFN-γ antibody for 24 h, in the presence of rhM-CSF and rhRANKL for 6 days. Then, BMMs were incubated with 2 mL FACS lysing solution at 25°C for 10 min, and incubated with FITC-conjugated anti-human RANK antibodies (Becton Dickinson) at 25°C for 30 min in the dark. The stained cells were analyzed using a FACS scan.
Cell viability detection by CCK8
The adherent BMMs were cultured with Th1 cells, with or without pre-incubated anti-IFN-γ antibody (1, 5 and 10 µg/ml) for 24 h, in the presence of rhM-CSF and rhRANKL for 24, 48, and 72 h. Then, BMMs were incubated with CCK8 solution (Beyotime, China) at 37 °C for 2 h. Cell viability was detected by a microplate reader at 450 nm.
Immunostaining of F-actin
After treatments, BMMs were fixed with 4% paraformaldehyde in PBS for 15 min and permeabilized with 100% methanol for 10 min at -20°C. After blocking with 2% goat serum for 60 min, the cells were treated with primary antibody against F-actin (1:100, Abcam, USA) and incubated overnight at 4°C. After incubating with fluorochrome-conjugated secondary antibody for 1 h at room temperature in the dark, the nuclei were stained using DAPI. The images were captured by FV10i Confocal Microscope (Olympus, Japan).
Tartrate-resistant acidic phosphatase (TRAP) staining
The adherent BMMs were cultured with Th1 cells with or without pre-incubated anti-IFN-γ antibody for 24 h, in the presence of rhM-CSF and rhRANKL for 6 days. Then, TRAP staining was performed using a TRAP staining kit (Sigma, USA) at 25°C Slides were viewed using a light microscope (10X, IX71, Olympus, Japan).
Bone absorbance assay
The adherent BMMs were cultured with Th1 cells with or without pre-incubated anti-IFN-γ antibody for 24 h, in the presence of rhM-CSF and rhRANKL for 6 days. Then, bone resorption function of differentiated osteoclasts was evaluated by the OsteoAssay Plate. Cells were seeded on plates. After induction by anti-IFN-γ antibody, the medium was removed, and 10% bleach was added. After 5 min, the plates were washed in ddH 2 O for 5 min. The formation of lacuna was observed on plates and imaged by light microscopy (10X, IX71, Olympus, Japan).
Statistical analysis
Data were performed in triplicate and presented as means ± standard deviation. The analysis was performed by SPSS 16.0 using student t-tests for two groups, and one-way ANOVA with SNK for multiple group comparisons. P < 0.05 was considered to be statistically significant. (1, 5, or 10 µg/mL for 24, 48, and 72 h, respectively. As shown in Fig. 1A , the CCK-8 assay revealed that cell viability of BMMs was significantly inhibited in a dose-dependent manner. In contrast, the negative control rabbit IgG antibody did not exhibit any significant changes in cell viability. These results suggested the optimal treatment condition of anti-IFN-γ antibody was 10 µg/ml for 48 h, which was selected for subsequent experiments.
Results
Anti-IFN-γ antibody suppressed cell proliferation and secretion of IFN-γ, but promoted the production of RANKL, TNF-α, MCP-1 and SDF-1
For chemokine production, pretreatment of tuberculosis-activated Th1 cells with anti-IFN-γ antibody, inhibited the production of IFN-γ (Fig. 1B) , but promoted the production of RANKL (Fig. 1C) , TNF-α (Fig. 1D), MCP-1 (Fig. 1E) and SDF-1 (Fig. 1F ) in co-cultured cells, by ELISA assay.
Anti-IFN-γ antibody reduced IFN-γ and OPG levels, but increased RANKL, TNF-α, NF-κB, and TRAF6 levels in BMMs
To investigate the mechanism of osteoclast differentiation by tuberculosis-activated Th1 cells pretreated with anti-IFN-γ antibody, we measured changes in levels of IFN-γ, OPG, RANKL, TNF-α, NF-κB, and TRAF6 in BMMs. After co-cultured BMMs and Th1 cells were treated with 10 µg/ml of anti-IFN-γ antibody for 6 days, the mRNA and protein levels of IFN-γ were significantly decreased ( Fig. 2A and F) , whereas the mRNA and protein levels of RANKL (Fig. 2B and F) , TNF-α ( Fig. 2C and F) , NF-κB ( Fig. 2D and F) , and TRAF6 ( Fig. 2E and F) were significantly increased. Moreover, the expression of OPG levels in BMMs were significantly inhibited by anti-IFN-γ antibody (Fig. 2F) .
anti-IFN-γ antibody promoted osteoclastogenesis in BMMs
To evaluate osteoclastogenesis in the presence of anti-IFN-γ antibody, we first detected the changes in RANK levels and actin ring formation (Fig. 3) . After co-cultured BMMs and Th1 cells were treated with 10 µg/ml of anti-IFN-γ antibody for 6 days, RANKL levels in BMMs were significantly increased (Fig. 3A) . Moreover, immunostaining of F-actin showed that anti-IFN-γ antibody increased actin ring formations in the peripheral margin of the BMMs (Fig. 3B) , indicating that anti-IFN-γ antibody promotes the differentiation of osteoclasts.
anti-IFN-γ antibody promoted resorption in BMMs
To confirm that osteoclasts are generated by stimulating BMMs with anti-IFN-γ antibody, TRAP staining and bone absorbance assays were performed (Fig. 4) . As shown in Fig. 4A and C, TRAP-positive multinucleated cells (containing three or more nuclei) dramatically improved when co-cultured with BMMs and 10 µg/ml of anti-IFN-γ antibody-pretreated Th1 cells. In addition, the ability to form bone lacuna increased significantly (Fig. 4B and D 
Discussion
In 2000, Joseph et al. put forward the concept of bone immunity, suggesting that there are common cytokines, transcription factors and receptors between immune cells and bone cells, which influence bone remodeling through cell-cell interactions and secretion factors [24] . Studies have demonstrated that activated T cells express RANKL and induce osteoclast differentiation, maturation and activation by binding to RANK on the surface of osteoclast precursors. It was further suggested that activated T cells affect bone metabolism and promote the formation of osteoclast and subsequent bone resorption by expressing RANKL in vivo and in vitro [25, 26] . In the present study, our results demonstrate that anti-IFN-γ antibody inhibits the expression of IFN-γ in Th1 cells and inhibits the cell proliferation and expression of OPG, promotes the expression and secretion of RANKL, TNF-α, MCP-1 and SDF-1 and expression of NF-κB and TRAF6. Consistently, the increase in actin ring formation, The Mycobacterium tuberculosis is mainly present in macrophages, and causes pathological changes in the body by stimulating the peripheral blood T lymphocytes [27] . Tuberculosis of bone refers to the Mycobacterium tuberculosis invading the bones or joints [28] . If the diagnosis and treatment of bone tuberculosis is not timely, it can cause spinal deformity, limited activity, and even paraplegia, seriously affecting the quality of life of the patients. Mycobacterium tuberculosis invades the body and multiplies in cells and causes an inflammatory response and therefore, disrupts the function of the immune system [29] . The immune mechanism of the host cells, thus plays an important role in the growth of Mycobacterium tuberculosis. TNF-α is a cytokine produced by lipopolysaccharidemediated macrophages, and has a variety of biological activities. IFN-γ is a lymphocyte-type interferon that constitutes a group of active cytokines with multiple functions produced by monocytes and lymphocytes. IFN-γ is expressed in bone tuberculosis tissues, and exhibits low expression in epithelial cells and lymphocytes, indicating that Mycobacterium tuberculosis invades the body and reduces the immune regulation ability of the body [30, 31] . Most studies suggest that INF-γ produced by activated Th1, strongly inhibits the in vitro differentiation of osteoclast precursor cells into osteoclasts [18, 19] . Kohara et al. reported that TNF-α induces the formation of osteoclasts [32] . IFN-γ directly inhibits the induction of osteoclasts by TNF-α by promoting Fas/FasL signaling-mediated osteoclast precursor cell apoptosis [32] . Takayanagi et al. found that IFN-γ strongly inhibits RANKL-induced activation of the transcription factors NF-κB and JNK by inducing rapid degradation of the adapter protein TRAF6 in the RANKL-RANK signaling pathway, blocking the entire RANKL-RANK signaling pathway and eventually inhibiting osteoclast formation [20] . In addition, Cheng et al. reported that IFN-γ inhibits the expression of genes that induce monocyte differentiation into osteoclasts by inhibiting the expression of NFATc1 and activation of NF-κB and JNK signaling [33] . In contrast, our results showed that anti-IFN-γ antibody inhibited the expression of IFN-γ in Th1 cells and promoted the secretion of RANKL and TNF-α, and the expressions of NF-κB and TRAF6. These data imply that anti-IFN-γ antibody induces RANKLinduced activation of the transcription factors NF-κB by inducing the adapter protein, TRAF6 in the RANKL-RANK signaling pathway, and eventually promoting osteoclast formation. Our data further suggest that IFN-γ influences osteoclastogenesis in BMMs through the RANKL-RANK signaling pathway.
Conclusion
The anti-IFN-γ antibody induces osteoclast formation, probably via RANKL-induced activation of NF-κB that induces TRAF6 in the RANKL-RANK signaling pathway. This suggests an inhibitory role of IFN-γ in osteoclast formation, which should be paid close attention to, in clinics.
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